Private equity now dominates the buyer side of home care M&A. In 2024, PE-backed platforms accounted for 62% of buyer-side transactions, up from 41% in 2020. For home care agency owners considering a sale, understanding how PE firms operate, what they value, and how they structure deals is no longer optional — it’s essential knowledge.
This guide covers everything sellers need to know about selling to a private equity buyer.
Private equity’s outsized interest in home care isn’t coincidental — it’s driven by a specific investment thesis that makes home care one of the most attractive healthcare services sectors for leveraged buyout strategies.
1. Recession-resistant demand Home care demand is driven by demographics, not consumer spending or GDP cycles. The aging Baby Boomer cohort creates 20+ years of non-discretionary demand growth that is largely immune to economic downturns.
2. Fragmented market ideal for consolidation 80%+ of home care agencies have annual revenue below $3M. This fragmentation creates the classic PE “buy-and-build” opportunity: acquire a platform, then add bolt-on acquisitions to build scale, drive synergies, and exit at a multiple arbitrage premium.
3. Repeatable EBITDA margins Home care agencies — particularly Medicare-certified and hospice businesses — generate highly predictable, recurring revenue with limited capital expenditure requirements. This profile suits the leveraged buyout model extremely well.
4. Multiple expansion potential A $1M EBITDA home care agency acquired at 4× ($4M) can become part of a $15M EBITDA platform that sells at 10× ($150M). The multiple arbitrage between the add-on price and the exit price is one of the primary sources of PE returns in this sector.
When a PE firm reviews your business, they’re looking at it through several lenses simultaneously:
PE deals are typically structured differently from strategic acquisitions. Understanding the components helps you evaluate and negotiate more effectively.
This is the total agreed-upon price for the business, expressed as a multiple of EBITDA. It’s the headline number — but not necessarily what you receive at close.
After adjusting for working capital, debt payoff, and transaction costs, most sellers receive 75–90% of enterprise value in cash at closing on a typical PE transaction.
Many PE buyers ask (or require) the seller to “roll” 10–25% of their proceeds into equity in the acquiring platform. This is called rollover equity or a “second bite of the apple.”
For sellers, rollover equity means:
Whether rollover equity is attractive depends entirely on the quality of the PE sponsor, the platform’s growth trajectory, and your personal risk tolerance. Your advisor should help you evaluate this critically.
An earnout ties a portion of your purchase price to post-close performance. For example: “We’ll pay you an additional $500K if the agency achieves $1.5M EBITDA in Year 2 post-close.”
Earnouts are most common when:
Earnouts introduce risk — post-close performance is influenced by decisions you may no longer control. In general, a higher cash-at-close offer with no earnout is preferable for most sellers to a higher headline price with significant earnout components.
Most PE buyers require the seller to remain available during a transition period — typically 6–18 months post-close. The structure ranges from a full-time employment contract to a part-time consulting agreement. Understanding this obligation before accepting an offer is critical.
The home care PE buyer universe is more active and better-capitalized than at any prior point in the market’s history. Over 80 PE-backed platforms are actively seeking acquisitions, including:
National platforms: Elara Caring, Addus HomeCare, Amedisys (post-Optum), and LHC Group entities — these buyers pay premium prices for operational scale.
Mid-market PE platforms: Dozens of PE-sponsored platforms with 2–8 existing locations actively seeking add-ons to complete their regional consolidation strategy.
Health system affiliates: Health systems using PE-style acquisition structures to build integrated post-acute care platforms.
Emerging platforms: Newly formed PE-backed entities specifically created to consolidate home care in one or more targeted geographies.
Working with a specialist M&A advisor like Hendon Partners gives you access to this entire buyer universe — not just the 2–3 buyers you might have heard of. The difference between a transaction run through 8 buyers and one run through 50 buyers is often measured in multiples of EBITDA.
Understand their thesis before your first meeting. The most effective sellers know what the PE firm is trying to build, why your agency fits their acquisition criteria, and how to position your business as solving their specific strategic problem.
Present a believable growth story. PE buyers are buying future cash flows, not just historical performance. Your CIM should clearly articulate the growth opportunities a well-capitalized new owner could capture — new referral relationships, geographic expansion, service line additions.
Never negotiate with one PE firm. Always run a competitive process. The presence of multiple buyers fundamentally changes the dynamic and consistently drives superior outcomes.
Scrutinize rollover equity terms. Don’t accept rollover equity without understanding the sponsor’s track record, the platform’s competitive position, and what the realistic exit scenarios look like in 3–5 years.
The honest answer: it depends. PE buyers typically pay higher multiples than individual or regional strategic buyers — but the transaction is more complex, the process is more rigorous, and the expectations for post-close performance are higher.
Strategic buyers (regional operators, health systems) often offer softer terms, faster closes, and more flexibility on earnout and rollover requirements — but typically at lower headline prices.
The right answer is determined by running a competitive process that includes both PE and strategic buyers, evaluating all offers holistically, and selecting the path that maximizes your total after-tax, risk-adjusted outcome.
Speak with Neli Gertner to understand which buyer type is the right target for your agency’s specific profile — and how Hendon Partners would approach building a competitive process designed exclusively to maximize your outcome.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
